B
Bertram Pitt
Researcher at University of Michigan
Publications - 834
Citations - 88351
Bertram Pitt is an academic researcher from University of Michigan. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 107, co-authored 754 publications receiving 78458 citations. Previous affiliations of Bertram Pitt include Rutgers University & Tufts Medical Center.
Papers
More filters
Journal ArticleDOI
Greater Efficacy With Amlodipine/valsartan Combination Intensive Vs Moderate Treatment For Hypertensive Patients With Cardiometabolic Syndrome Uncontrolled On Arb Monotherapy: Pp.34.432
James R. Sowers,Thomas D. Giles,Elizabeth Ofili,Bertram Pitt,Yodit Seifu,Rita Samuel,Robert Hilkert,Suzanne Oparil +7 more
TL;DR: Initiating treatment in hypertensive MetS pts with an intensive dose of A/V provided significantly greater antihypertensive efficacy than moderate treatment.
Journal ArticleDOI
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease
Bertram Pitt,Rajiv Agarwal,Stefan D. Anker,Luis M. Ruilope,Peter Rossing,Christiane Ahlers,Meike Brinker,Amer Joseph,Marc Lambelet,Robert Lawatscheck,Gerasimos Filippatos +10 more
TL;DR: Findings suggest that mineralocorticoid receptor blockade with finerenone was associated with protection against pneumonia and COVID-19 adverse events in patients with type 2 diabetes and chronic kidney disease.
Journal ArticleDOI
Triple combination therapy with amlodipine/valsartan/hctz at maximal doses is safe and effective for hypertensive patients uncontrolled on arb monotherapy: the extra study: pp.5.216
Suzanne Oparil,Thomas D. Giles,Elizabeth Ofili,Bertram Pitt,Yodit Seifu,Rita Samuel,Robert Hilkert,James R. Sowers +7 more
TL;DR: Use of triple combination A/V/HCTZ with maximal dose of 10/320/25 mg is safe for pts who are able to up-titrate and results in additional BP reduction.